FDA Inspection 730681 — Hunterdon Medical Center Blood Bank
The FDA completed an inspection of Hunterdon Medical Center Blood Bank on Jul 18, 2011 in Flemington, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 18, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Flemington, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 4425 | 21 CFR 606.60(a) | Equipment observed, standardized, calibrated |
| 76 | 21 CFR 606.100(b) | Establish, maintain and follow manufacturing SOPs |
| 78 | 21 CFR 606.100(c) | Record review prior to release |
| 93 | 21 CFR 606.100(b)(14) | QC procedures for supplies and reagents |
| 98 | 21 CFR 606.100(c) | Thorough investigations |